⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL83826 | 0.63 | — | — | |
| SCHEMBL29068297 | 0.60 | — | — | |
| SCHEMBL30196030 | 0.60 | — | — | |
| Hydrochloric Acid SCHEMBL27782796 | 0.60 | — | — | |
| SCHEMBL538494 | 0.59 | — | — | |
| SCHEMBL30905995 | 0.59 | — | — | |
| SCHEMBL9653572 | 0.59 | — | — | |
| Hydrochloric Acid SCHEMBL10925085 | 0.59 | — | — | |
| Formaldehyde SCHEMBL27842049 | 0.59 | — | — | |
| SCHEMBL9200523 | 0.57 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1599460-B1 | OXATHIIN CARBOXAMIDE | BAYER CROPSCIENCE AG (DE) | 2007-11-07 | — | — | EP | claimed |
| US-20070004793-A1 | such as N-[2-(4-bromophenyl)phenyl]-6-trifluoromethyl-2,3-dihydro-1,4-oxathiine-5-carboxamide, used for controlling unwanted microorganisms, for example, bacteria, fungi, yeasts, algae and slime organisms | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2007-01-04 | — | — | US | claimed |
| JP-58134085-A | — | — | None | — | — | JP | disclosed |
| US-9812315-B2 | Treating solution for electronic parts, and process for producing electronic parts | FINE POLYMERS CORPORATION (JP) | 2017-11-07 | — | — | US | disclosed |
| US-20150279654-A1 | TREATING SOLUTION FOR ELECTRONIC PARTS, AND PROCESS FOR PRODUCING ELECTRONIC PARTS | FINE POLYMERS CORPORATION (JP) | 2015-10-01 | — | — | US | disclosed |
| CN-102459166-B | Azetidinyl diamides as monoacylglycerol lipase inhibitors | JANSSEN PHARMACEUTICA NV | 2015-03-25 | — | — | CN | disclosed |
| CN-102803210-A | Azetidinyl diamides as monoacylglycerol lipase inhibitors | JANSSEN PHARMACEUTICA NV | 2012-11-28 | — | — | CN | disclosed |
| CN-102548982-A | Azetidinyl diamides as monoacylglycerol lipase inhibitors | JANSSEN PHARMACEUTICA NV | 2012-07-04 | — | — | CN | disclosed |
| CN-102459228-A | Azetidinyl diamides as monoacylglycerol lipase inhibitors | JANSSEN PHARMACEUTICA NV | 2012-05-16 | — | — | CN | disclosed |
| CN-102459166-A | Azetidinyl diamides as monoacylglycerol lipase inhibitors | JANSSEN PHARMACEUTICA NV | 2012-05-16 | — | — | CN | disclosed |
| US-7847108-B2 | such as N-[2-(4-bromophenyl)phenyl]-6-trifluoromethyl-2,3-dihydro-1,4-oxathiine-5-carboxamide, used for controlling unwanted microorganisms, for example, bacteria, fungi, yeasts, algae and slime organisms | BAYER CROPSCIENCE AG (DE) | 2010-12-07 | — | — | US | disclosed |
| US-20070004793-A1 | such as N-[2-(4-bromophenyl)phenyl]-6-trifluoromethyl-2,3-dihydro-1,4-oxathiine-5-carboxamide, used for controlling unwanted microorganisms, for example, bacteria, fungi, yeasts, algae and slime organisms | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2007-01-04 | — | — | US | disclosed |
| CN-1774432-A | Oxatiincarboxamidas | BAYER CROPSCIENCE AG (DE) | 2006-05-17 | — | — | CN | disclosed |
| CN-1051036-A | The treatment of HIV (human immunodeficiency virus) infections and in treatment used compound | UNIROYAL CHEM CO INC (US) | 1991-05-01 | — | — | CN | disclosed |
| JP-S58134085-A | NOVEL OXATHIINCARBOXYLIC ACID AND PREPARATION THEREOF | TAKEDA CHEM IND LTD | 1983-08-10 | — | — | JP | disclosed |